Sanofi Loses Bid To Dismiss Claims Over Arava

Law360, New York (January 18, 2008, 12:00 AM EST) -- A judge has denied Sanofi-Aventis' motion to dismiss antitrust claims accusing the company of unlawfully blocking generic competition for Sanofi's rheumatoid arthritis treatment Arava by filing a sham Citizen Petition with the U.S. Food and Drug Administration.

The lawsuit was filed by Louisiana Wholesale Drug Co. Inc. against Sanofi-Aventis, Sanofi-Aventis US LLC and Aventis Pharmaceuticals Inc. in the U.S. District Court for the Southern District of New York in August.

The drug at the center of the suit is leflunomide, which is sold under the brand...
To view the full article, register now.